NEOCIRCULATION (7FP-HEALTH funded consortium) has developed an age appropriate formulation of Dobutamine for the use in newborn infants.
The aims of our project are to study this age appropriate formulation in preterm infants to obtain a licenced drug and to work towards a new definition of neonatal shock.
After completing preparatory work and a pilot study we would like to conduct a large randomised study in infants < 33 weeks gestation.
We are now open for recruiting additional study centres.
If you would be interested in more information and in joining the study please email the clinical study project manager at: email@example.com.